China to push for domestic med devices; COSMED's Bellini has prospective industry take; India's med tech market retracts on China's incentives;

@FierceMedDev: ICYMI: Done deal: Medtronic to buy Covidien for $42.9B. Story | Follow @FierceMedDev

@StacyALawrence: iWatch to unite Apple healthcare strategy? Article | Follow @StacyALawrence

@MichaelGFierce: UPenn team combats Parkinson's with immunotherapy that targets neuron killers. More | Follow @MichaelGFierce

@EmilyWFierce: "Strokefinder" microwave helmet could provide a portable, quick way to diagnose strokes in ambulances. News | Follow @EmilyWFierce

> China will promote its domestic medical equipment producers by publishing a catalog of selected products, in hopes manufacturers will vie for a spot. Article

> Claudio Bellini, COO of COSMED USA, opines on the future of med tech in light of stronger regulation and new technology. More

> The growth of India's med device industry is stymied by competition in the Asia Pacific, namely China. More

Biotech News

@FierceBiotech: Pfizer, Novartis race to market with 'breakthrough' meningitis B vaccines. Story | Follow @FierceBiotech

@JohnCFierce: Selecta ramps up a gout program, gets more cash for vaccine R&D. News | Follow @JohnCFierce

@DamianFierce: As you head home from 2014 ADA, check out FiercePharma's rundown of the best-selling diabetes drugs. More | Follow @DamianFierce

> True North snags $22M and sets course for the clinic with a rare disease drug. More

> Merck KGaA pulls the plug on Ono's MS drug as the market crowds. Article

> GW spikes on positive results for cannabis-based epilepsy drug. Item

Pharma News

@FiercePharma: Our newest report, now live: The top 10 best-selling diabetes drugs of 2013. Story | Follow @FiercePharma

@TracyStaton: Trending now at FiercePharma: Novo Nordisk lays out plans to recruit 6,000 workers in R&D, production. More | Follow @TracyStaton

@EricPFierce: India's Lupin wants to buy capacity in EU in biosimilars, inhalation drugs to build markets there. News | Follow @EricPFierce

@CarlyHFierce: Expecting hostile suitors, Shire brings in reinforcements. More | Follow @CarlyHFierce

@JustinHFierce: The USDA licenses first vaccine for Porcine Epidemic Diarhea Virus (PEDv), 7mil pigs already dead since outbreak. News | Follow @JustinHFierce

> Merck seeks sanctions against Brown U doc over Vioxx comments. More

> With Pfizer's bid dead, AstraZeneca chief promises eyes on goal. Article

Biotech Research News

> UPenn team combats Parkinson's with immunotherapy that targets neuron killers. More

> Party drug ketamine shows potential as rapid-acting therapy for depression. Article

> Copper compound increases survival in mice with ALS. News

> Type 1 diabetes reversed in mice. Item

> Think tank: $4.5B investment in BRAIN project too modest. Report

> NIH would get 2% budget hike under Senate bill. More

Pharma Manufacturing News

> Health Canada lets Biolyse restore production of paclitaxel. News

> OSHA fines a Wisconsin API maker that no longer exists almost half a million. More

> FDA approves Novartis U.S. vaccine plant it is trying to sell. Article

> India's Lupin ready to spend $1B to bulk up in EU. Story

> Grand River Aseptic Manufacturing gets $9.8M boost. Report

> FDA says Apotex India plant has faked data for years. Item

Suggested Articles

The FDA has cleared its first fully disposable duodenoscope, following years of reports of infections being transmitted between patients.

OR-focused AI provider Caresyntax has garnered $45.6 million in new funding and picked up a data analytics firm to broaden its footprint.

A study of Foundation Medicine’s FoundationOne liquid biopsy test found it was able to predict the risk that a person’s breast cancer would return.